Quick Links

Contact Us

Erectile dysfunction and cardiovascular risk factors.

Authors: R A Kloner

Journal: Hospital practice (1995)

Publication Type: Journal Article

Date: 2001

DOI: 10.3810/hp.2001.08.246

ID: 11515777

Affiliations:

Affiliations

    Section of Cardiology, University of Southern California Keck School of Medicine, Los Angeles, USA.

Abstract

Erectile dysfunction (ED) affects as many as 30 million men in the United States. Its risk factors are similar to those for atherosclerotic heart disease. Physicians should ask male patients--particularly those with cardiovascular disease--about ED and men with confirmed ED about cardiovascular risk factors. Oral sildenafil is an effective therapy for both organic and psychogenic ED; it is contraindicated in patients taking organic nitrates.

Chemical List

    Phosphodiesterase Inhibitors|||Piperazines|||Purines|||Sulfones|||Sildenafil Citrate